BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33754896)

  • 1. Identification of hub ubiquitin ligase genes affecting Alzheimer's disease by analyzing transcriptome data from multiple brain regions.
    Liu D; Dai SX; He K; Li GH; Liu J; Liu LG; Huang JF; Xu L; Li WX
    Sci Prog; 2021; 104(1):368504211001146. PubMed ID: 33754896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulation and Computational Study of RING Domain Mutants of BRCA1 and Ube2k in AD/PD Pathophysiology.
    Sahu M; Rani N; Kumar P
    Mol Biotechnol; 2024 May; 66(5):1095-1115. PubMed ID: 38172369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer's Disease.
    Al Mamun A; Uddin MS; Kabir MT; Khanum S; Sarwar MS; Mathew B; Rauf A; Ahmed M; Ashraf GM
    Neurotox Res; 2020 Jun; 38(1):8-17. PubMed ID: 32157628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic Analysis and Experimental Validation of Ubiquitin-Proteasomal System-Related Hub Genes as Novel Biomarkers for Alzheimer's Disease.
    Zhang Y; Wu J; You G; Guo W; Wang Y; Yu Z; Geng Y; Zhong Q; Zan J; Zheng L
    J Integr Neurosci; 2023 Oct; 22(6):138. PubMed ID: 38176925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin.
    Vriend J; Klonisch T
    Cell Mol Neurobiol; 2023 May; 43(4):1425-1452. PubMed ID: 35896929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Insight into the Crosstalk of UPS Components and Alzheimer's Disease.
    Al Mamun A; Rahman MM; Zaman S; Munira MS; Uddin MS; Rauf A; Banu N; Ashraf GM
    Curr Protein Pept Sci; 2020; 21(12):1193-1201. PubMed ID: 32964822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin ligases and medulloblastoma: genetic markers of the four consensus subgroups identified through transcriptome datasets.
    Vriend J; Rastegar M
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165839. PubMed ID: 32445667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of Aberrant E3 Ligases Implicated in Alzheimer's Disease and Development of Chemical Tools to Modulate Their Function.
    Potjewyd FM; Axtman AD
    Front Cell Neurosci; 2021; 15():768655. PubMed ID: 34867205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide identification and transcriptome profiling reveal that E3 ubiquitin ligase genes relevant to ethylene, auxin and abscisic acid are differentially expressed in the fruits of melting flesh and stony hard peach varieties.
    Tan B; Lian X; Cheng J; Zeng W; Zheng X; Wang W; Ye X; Li J; Li Z; Zhang L; Feng J
    BMC Genomics; 2019 Nov; 20(1):892. PubMed ID: 31752682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treadmill exercise promotes E3 ubiquitin ligase to remove amyloid β and P-tau and improve cognitive ability in APP/PS1 transgenic mice.
    Xu L; Li M; Wei A; Yang M; Li C; Liu R; Zheng Y; Chen Y; Wang Z; Wang K; Wang T
    J Neuroinflammation; 2022 Oct; 19(1):243. PubMed ID: 36195875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Regulatory Genes and Pathways in Prefrontal Cortex of Alzheimer's Disease.
    Yang F; Diao X; Wang F; Wang Q; Sun J; Zhou Y; Xie J
    Interdiscip Sci; 2020 Mar; 12(1):90-98. PubMed ID: 32006383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between amyloid-beta and the ubiquitin-proteasome system in Alzheimer's disease.
    Hong L; Huang HC; Jiang ZF
    Neurol Res; 2014 Mar; 36(3):276-82. PubMed ID: 24512022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ubiquitin System in Alzheimer's Disease.
    Harris LD; Jasem S; Licchesi JDF
    Adv Exp Med Biol; 2020; 1233():195-221. PubMed ID: 32274758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkin reverses intracellular beta-amyloid accumulation and its negative effects on proteasome function.
    Rosen KM; Moussa CE; Lee HK; Kumar P; Kitada T; Qin G; Fu Q; Querfurth HW
    J Neurosci Res; 2010 Jan; 88(1):167-78. PubMed ID: 19610108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating peripheral blood and brain transcriptomics to identify immunological features associated with Alzheimer's disease in mild cognitive impairment patients.
    Qian XH; Liu XL; Chen SD; Tang HD
    Front Immunol; 2022; 13():986346. PubMed ID: 36159817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
    Tank EM; True HL
    PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of oxidative stress-related genes differentially expressed in Alzheimer's disease and construction of a hub gene-based diagnostic model.
    Zhang Y; Kiryu H
    Sci Rep; 2023 Apr; 13(1):6817. PubMed ID: 37100862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systems analysis of human brain gene expression: mechanisms for HIV-associated neurocognitive impairment and common pathways with Alzheimer's disease.
    Levine AJ; Miller JA; Shapshak P; Gelman B; Singer EJ; Hinkin CH; Commins D; Morgello S; Grant I; Horvath S
    BMC Med Genomics; 2013 Feb; 6():4. PubMed ID: 23406646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TTC3-Mediated Protein Quality Control, A Potential Mechanism for Cognitive Impairment.
    Zhou X; Chen X; Hong T; Zhang M; Cai Y; Cui L
    Cell Mol Neurobiol; 2022 Aug; 42(6):1659-1669. PubMed ID: 33638766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of N6-methyladenosine (m6A) modification on cell phenotype in Alzheimer's disease.
    Ni P; Pan K; Zhao B
    PLoS One; 2023; 18(8):e0289068. PubMed ID: 37549144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.